Urapidil-d3 (methoxy-d3) is a deuterated active pharmaceutical ingredient, specifically a labeled version of urapidil where the methoxy group contains three deuterium atoms. This compound is primarily used in pharmaceutical research and development as an internal standard or tracer for analytical studies.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1398066-08-4
Nicotinic-d4 Acid
pharmaceutical raw material
(+/-)-Ondansetron-d5 (methylimidazole-d5)
pharmaceutical raw material
Rifaximin-d6 (Major)
pharmaceutical raw material
(1S,3R,4S)-quinuclidin-3-yl (S)-1-(phenyl-d5)-3,4-dihydroisoquinoline-2(1H)-carboxylate
pharmaceutical raw material
Sarolaner
pharmaceutical raw material
Cetylpyridinium bromide
pharmaceutical raw material
Nystatin
pharmaceutical raw material
Metopimazine
pharmaceutical raw material
1,3-dimethyl-6-[3-[4-[2-(trideuteriomethoxy)phenyl]piperazin-1-yl]propylamino]pyrimidine-2,4-dione
ICMGLRUYEQNHPF-HPRDVNIFSA-N
[2H]C([2H])([2H])OC1=CC=CC=C1N2CCN(CC2)CCCNC3=CC(=O)N(C(=O)N3C)C